| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units
|
Petit, T.
|
|
|
10 |
4 |
p. 449-453
|
artikel
|
| 2 |
Activity of SCH 66336, a tricyclic farnesyltransferase inhibitor, against human tumor colony-forming units
|
T. Petit
|
|
1999
|
10 |
4 |
p. 449-453
5 p.
|
artikel
|
| 3 |
Angiogenesis and Anti-Angiogenesis: Perspectives for the Treatment of Solid Tumors
|
Victor W.M. van Hinsbergh
|
|
1999
|
10 |
4 |
p. 60-63
4 p.
|
artikel
|
| 4 |
An Overview of Preventive Strategies for Pancreatic Cancer
|
Bernard Levin
|
|
1999
|
10 |
4 |
p. 193-196
4 p.
|
artikel
|
| 5 |
Authors Index
|
|
|
1999
|
10 |
4 |
p. 317-318
2 p.
|
artikel
|
| 6 |
Awards, appointments
|
|
|
|
10 |
4 |
p. 367
|
artikel
|
| 7 |
Biliopancreatic Malignancy Current Diagnostic Possibilities: An Overview
|
J.T. Ferrucci
|
|
1999
|
10 |
4 |
p. 143-144
2 p.
|
artikel
|
| 8 |
Biliopancreatic Malignancy: Future Prospects for Progress
|
Jenny J.L. Ho
|
|
1999
|
10 |
4 |
p. 300-304
5 p.
|
artikel
|
| 9 |
Biliopancreatic Malignancy: Screening the at Risk Patient with Molecular Markers
|
C. Caldas
|
|
1999
|
10 |
4 |
p. 153-156
4 p.
|
artikel
|
| 10 |
Book review
|
Obrist, R.
|
|
|
10 |
4 |
p. 372
|
artikel
|
| 11 |
Book review
|
Bernier, J.
|
|
|
10 |
4 |
p. 474
|
artikel
|
| 12 |
Chemoradiation for Pancreatic and Biliary Cancer: Current Status of RTOG Studies
|
Tyvin A. Rich
|
|
1999
|
10 |
4 |
p. 231-233
3 p.
|
artikel
|
| 13 |
Choledochal Cystic Malignancies
|
H. Bismuth
|
|
1999
|
10 |
4 |
p. 94-98
5 p.
|
artikel
|
| 14 |
Clinical outcome after autologous transplantation in non-Hodgkin’s lymphoma patients with high international prognostic index (IPI)
|
Cortelazzo, S.
|
|
|
10 |
4 |
p. 427-432
|
artikel
|
| 15 |
Clinical outcome after autologous transplantation in non-Hodgkins lymphoma patients with high international prognostic index (IPI)
|
S. Cortelazzo
|
|
1999
|
10 |
4 |
p. 427-432
6 p.
|
artikel
|
| 16 |
Complications after Resection of Biliopancreatic Cancer
|
Dirk J. Gouma
|
|
1999
|
10 |
4 |
p. 257-260
4 p.
|
artikel
|
| 17 |
Computed Tomography in the Diagnosis and Staging of Cholangiocarcinoma and Pancreatic Carcinoma
|
Patrick C. Freeny
|
|
1999
|
10 |
4 |
p. 12-17
6 p.
|
artikel
|
| 18 |
Conformal irradiation for hepatobiliary malignancies
|
L. L. Gunderson
|
|
1999
|
10 |
4 |
p. 221-225
5 p.
|
artikel
|
| 19 |
Contents of the next issue
|
|
|
|
10 |
4 |
p. vi
|
artikel
|
| 20 |
Copyright
|
|
|
|
10 |
4 |
p. iv
|
artikel
|
| 21 |
Creation of a European drug development network
|
|
|
|
10 |
4 |
p. 365
|
artikel
|
| 22 |
Creation of a European drug development network; Marketing of temozolomide in Europe; What after managed care?; Europe for moratorium on xenotransplantation; Euthanasia advisory board in the Netherlands; Awards, appointments; Perhaps not everyone knows that...
|
|
|
1999
|
10 |
4 |
p. 365-371
7 p.
|
artikel
|
| 23 |
Current Chemotherapeutic Possibilities in Pancreaticobiliary Cancer
|
J.M.G.H. van Riel
|
|
1999
|
10 |
4 |
p. 157-161
5 p.
|
artikel
|
| 24 |
Cystic Pancreatic Neoplasms
|
David W. Rattner
|
|
1999
|
10 |
4 |
p. 104-106
3 p.
|
artikel
|
| 25 |
Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: Case report and review of the literature
|
Breathnach, O.
|
|
|
10 |
4 |
p. 461-465
|
artikel
|
| 26 |
Cytomegalovirus pneumonia in a patient with breast cancer on chemotherapy: Case report and review of the literature
|
O. Breathnach
|
|
1999
|
10 |
4 |
p. 461-465
5 p.
|
artikel
|
| 27 |
Detection of Micrometastasis in Bone Marrow of Pancreatic Cancer Patients
|
S. Thorban
|
|
1999
|
10 |
4 |
p. 111-113
3 p.
|
artikel
|
| 28 |
Diabetes and the Risk of Pancreatic Cancer
|
Lucio Gullo
|
|
1999
|
10 |
4 |
p. 79-81
3 p.
|
artikel
|
| 29 |
Diagnosis of Pancreatico-Biliary Malignancy: Detection of Gene Mutations in Plasma and Stool
|
H. Mulcahy
|
|
1999
|
10 |
4 |
p. 114-117
4 p.
|
artikel
|
| 30 |
Differential Diagnosis of Focal Pancreatitis and Pancreatic Cancer
|
T.M. van Gulik
|
|
1999
|
10 |
4 |
p. 85-88
4 p.
|
artikel
|
| 31 |
Does a gene in the Xq28 region increase the risk of non-Hodgkin’s lymphomas?
|
Vineis, P.
|
|
|
10 |
4 |
p. 471-473
|
artikel
|
| 32 |
Does a gene in the Xq28 region increase the risk of non-Hodgkins lymphomas?
|
P. Vineis
|
|
1999
|
10 |
4 |
p. 471-473
3 p.
|
artikel
|
| 33 |
DPC4/SMAD4 Gene Alterations in Human Cancer, and Their Functional Implications
|
Mieke Schutte
|
|
1999
|
10 |
4 |
p. 56-59
4 p.
|
artikel
|
| 34 |
Drug combinations: Dangerous liaisons or great expectations?
|
Ratain, M.J.
|
|
|
10 |
4 |
p. 375-376
|
artikel
|
| 35 |
Drug combinations: Dangerous liaisons or great expectations?
|
M. J. Ratain
|
|
1999
|
10 |
4 |
p. 375-376
2 p.
|
artikel
|
| 36 |
Editorial Board
|
|
|
|
10 |
4 |
p. v
|
artikel
|
| 37 |
Endoscopic Palliative Treatment of Advanced Pancreatic Cancer: Thoracoscopic Splanchnicectomy and Laparoscopic Gastrojejunostomy
|
G. Giraudo
|
|
1999
|
10 |
4 |
p. 278-280
3 p.
|
artikel
|
| 38 |
Essential drugs for cancer therapy: A World Health Organization consultation
|
Sikora, K.
|
|
|
10 |
4 |
p. 385-390
|
artikel
|
| 39 |
Essential drugs for cancer therapy: A World Health Organization consultation
|
K. Sikora
|
|
1999
|
10 |
4 |
p. 385-390
6 p.
|
artikel
|
| 40 |
Essentials in Biliopancreatic Staging: A Decision Analysis
|
H. Obertop
|
|
1999
|
10 |
4 |
p. 150-152
3 p.
|
artikel
|
| 41 |
Europe for moratorium on xenotransplantation
|
|
|
|
10 |
4 |
p. 366
|
artikel
|
| 42 |
Euthanasia advisory board in the Netherlands
|
|
|
|
10 |
4 |
p. 366-367
|
artikel
|
| 43 |
Experimental Drugs and Drug Combinations in Pancreatic Cancer
|
J.R. Kroep
|
|
1999
|
10 |
4 |
p. 234-238
5 p.
|
artikel
|
| 44 |
Familial Pancreatic Cancer
|
R. H. Hruban
|
|
1999
|
10 |
4 |
p. 69-73
5 p.
|
artikel
|
| 45 |
18FDG-Positron Emission Tomography in Pancreatic Cancer
|
Michael Zimny
|
|
1999
|
10 |
4 |
p. 28-32
5 p.
|
artikel
|
| 46 |
Future Role of Radiotherapy as a Component of Treatment in Biliopancreatic Cancers
|
L. L. Gunderson
|
|
1999
|
10 |
4 |
p. 291-295
5 p.
|
artikel
|
| 47 |
Gallbladder Carcinoma
|
Bernard Levin
|
|
1999
|
10 |
4 |
p. 129-130
2 p.
|
artikel
|
| 48 |
Gene Therapy for Pancreatic and Biliary Malignancies
|
R.J. Aspinall
|
|
1999
|
10 |
4 |
p. 188-192
5 p.
|
artikel
|
| 49 |
Histological and Genetic Changes in Malignant Transformation of Gallbladder Adenoma
|
H. Watanabe
|
|
1999
|
10 |
4 |
p. 136-139
4 p.
|
artikel
|
| 50 |
Imaging and Staging of Biliopancreatic Malignancy: Role of Ultrasound
|
N.J. Smits
|
|
1999
|
10 |
4 |
p. 20-24
5 p.
|
artikel
|
| 51 |
Imaging and Staging of Bilio-Pancreatic Tumours: Role of Endoscopic and Intraductal Ultrasonography and Guided Cytology
|
L. Palazzo
|
|
1999
|
10 |
4 |
p. 25-27
3 p.
|
artikel
|
| 52 |
Imaging of Pancreatic Adenocarcinoma with Radiolabeled Monoclonal Antibodies
|
G. Mariani
|
|
1999
|
10 |
4 |
p. 37-40
4 p.
|
artikel
|
| 53 |
Induction of λ-glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients
|
Oguri, T.
|
|
|
10 |
4 |
p. 455-460
|
artikel
|
| 54 |
Induction of -glutamylcysteine synthetase gene expression by platinum drugs in peripheral mononuclear cells of lung cancer patients
|
T. Oguri
|
|
1999
|
10 |
4 |
p. 455-460
6 p.
|
artikel
|
| 55 |
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival
|
Sarris, A.H.
|
|
|
10 |
4 |
p. 433-440
|
artikel
|
| 56 |
Interleukin-10 levels are often elevated in serum of adults with Hodgkins disease and are associated with inferior failure-free survival
|
A. H. Sarris
|
|
1999
|
10 |
4 |
p. 433-440
8 p.
|
artikel
|
| 57 |
In this issue
|
|
|
|
10 |
4 |
p. vi
|
artikel
|
| 58 |
Intraoperative Methods to Stage and Localize Pancreatic and Duodenal Tumors
|
Jeffrey A. Norton
|
|
1999
|
10 |
4 |
p. 182-184
3 p.
|
artikel
|
| 59 |
Intravenous and Intra-Arterial Chemotherapeutic Possibilities in Biliopancreatic Cancer
|
C.J. van Groeningen
|
|
1999
|
10 |
4 |
p. 305-307
3 p.
|
artikel
|
| 60 |
Introduction
|
G.N.J. Tytgat
|
|
1999
|
10 |
4 |
p. 7-7
1 p.
|
artikel
|
| 61 |
Invasion and Metastasis in Pancreatic Cancer
|
V. Ellenrieder
|
|
1999
|
10 |
4 |
p. 46-50
5 p.
|
artikel
|
| 62 |
In Vitro Pancreatic Carcinogenesis
|
B.M. Schmied
|
|
1999
|
10 |
4 |
p. 41-45
5 p.
|
artikel
|
| 63 |
K. T. Robbins (ed)., Advances in head and neck oncology
|
J. Bernier
|
|
1999
|
10 |
4 |
p. 474-474
1 p.
|
artikel
|
| 64 |
Laparoscopic Staging of Biliopancreatic Malignancy
|
Dirk J. Gouma
|
|
1999
|
10 |
4 |
p. 33-36
4 p.
|
artikel
|
| 65 |
Local Resection of Benign Periampullary Tumors
|
F. Treitschke
|
|
1999
|
10 |
4 |
p. 212-214
3 p.
|
artikel
|
| 66 |
Local Resection of Biliopancreatic Cancer
|
T.M. van Gulik
|
|
1999
|
10 |
4 |
p. 243-246
4 p.
|
artikel
|
| 67 |
Management of reactivated HBV infection following intensive chemotherapy for malignancy
|
Patton, N.
|
|
|
10 |
4 |
p. 484
|
artikel
|
| 68 |
Management of reactivated HBV infection following intensive chemotherapy for malignancy
|
N. Patton
|
|
1999
|
10 |
4 |
p. 484-484
1 p.
|
artikel
|
| 69 |
Marketing of temozolomide in Europe
|
|
|
|
10 |
4 |
p. 365
|
artikel
|
| 70 |
Mechanisms of Biliary Carcinogenesis: A Pathogenetic Multi-Stage Cascade towards Cholangiocarcinoma
|
F. Holzinger
|
|
1999
|
10 |
4 |
p. 122-126
5 p.
|
artikel
|
| 71 |
Metaplastic breast cancer: Prognosis and response to systemic therapy
|
Rayson, D.
|
|
|
10 |
4 |
p. 413-419
|
artikel
|
| 72 |
Metaplastic breast cancer: Prognosis and response to systemic therapy
|
D. Rayson
|
|
1999
|
10 |
4 |
p. 413-419
7 p.
|
artikel
|
| 73 |
M. L. Slevin & T. Tate (eds)., Cancer: How worthwhile is non-curative treatment?
|
R. Obrist
|
|
1999
|
10 |
4 |
p. 372-372
1 p.
|
artikel
|
| 74 |
MRI and MRCP in Pancreaticobiliary Malignancy
|
J.T. Ferrucci
|
|
1999
|
10 |
4 |
p. 18-19
2 p.
|
artikel
|
| 75 |
Mucin Gene and Antigen Expression in Biliopancreatic Carcinogenesis
|
Y. S. Kim
|
|
1999
|
10 |
4 |
p. 51-55
5 p.
|
artikel
|
| 76 |
Mucin Hypersecreting Neoplasms
|
David L. Carr-Locke
|
|
1999
|
10 |
4 |
p. 99-103
5 p.
|
artikel
|
| 77 |
Multidrug Resistance: A Solvable Problem?
|
Piet Borst
|
|
1999
|
10 |
4 |
p. 162-164
3 p.
|
artikel
|
| 78 |
Novel Technology for Detection of Genomic and Transcriptional Alterations in Pancreatic Cancer
|
C. Wallrapp
|
|
1999
|
10 |
4 |
p. 64-68
5 p.
|
artikel
|
| 79 |
Nutritional Support during Treatment of Biliopancreatic Malignancy
|
Maarten F. von Meyenfeldt
|
|
1999
|
10 |
4 |
p. 273-277
5 p.
|
artikel
|
| 80 |
Other Risk Factors for Pancreatic Cancer: Hormonal Aspects
|
Å. Andrén-Sandberg
|
|
1999
|
10 |
4 |
p. 131-135
5 p.
|
artikel
|
| 81 |
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
|
Fountzilas, G.
|
|
|
10 |
4 |
p. 475-478
|
artikel
|
| 82 |
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
|
G. Fountzilas
|
|
1999
|
10 |
4 |
p. 475-478
4 p.
|
artikel
|
| 83 |
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results*
|
Holmes, F.A.
|
|
|
10 |
4 |
p. 403-411
|
artikel
|
| 84 |
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
|
F. A. Holmes
|
|
1999
|
10 |
4 |
p. 403-411
9 p.
|
artikel
|
| 85 |
Pain Management of Pancreatic Cancer
|
Åke Andrén-Sandberg
|
|
1999
|
10 |
4 |
p. 265-268
4 p.
|
artikel
|
| 86 |
Palliation of Pain and Jaundice: An Overview
|
R.C.G. Russell
|
|
1999
|
10 |
4 |
p. 165-169
5 p.
|
artikel
|
| 87 |
Pancreatic Cancer: Clinical Presentation, Pitfalls and Early Clues
|
E. P. DiMagno
|
|
1999
|
10 |
4 |
p. 140-142
3 p.
|
artikel
|
| 88 |
Pancreatic Endocrine Tumors: Recent Advances
|
R. T. Jensen
|
|
1999
|
10 |
4 |
p. 170-176
7 p.
|
artikel
|
| 89 |
Pancreatic Endocrine Tumours, Immunotherapy and Gene Therapy: Chemotherapy and Interferon Therapy of Endocrine Tumours
|
C.H.N. Veenhof
|
|
1999
|
10 |
4 |
p. 185-187
3 p.
|
artikel
|
| 90 |
Pancreaticobiliary Cancer: The Future Aspects of Medical Oncology
|
J.M.G.H. van Riel
|
|
1999
|
10 |
4 |
p. 296-299
4 p.
|
artikel
|
| 91 |
Pancreatico-Biliary Malignancy: Prevalence and Risk Factors
|
Albert B. Lowenfels
|
|
1999
|
10 |
4 |
p. 1-3
3 p.
|
artikel
|
| 92 |
Pathology of Incipient Pancreatic Cancer
|
R. H. Hruban
|
|
1999
|
10 |
4 |
p. 9-11
3 p.
|
artikel
|
| 93 |
Perhaps not everyone knows that…
|
|
|
|
10 |
4 |
p. 367-371
|
artikel
|
| 94 |
Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
|
Colombo, T.
|
|
|
10 |
4 |
p. 391-395
|
artikel
|
| 95 |
Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin
|
T. Colombo
|
|
1999
|
10 |
4 |
p. 391-395
5 p.
|
artikel
|
| 96 |
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors
|
van Moorsel, C.J.A.
|
|
|
10 |
4 |
p. 441-448
|
artikel
|
| 97 |
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors
|
C. J. A. van Moorsel
|
|
1999
|
10 |
4 |
p. 441-448
8 p.
|
artikel
|
| 98 |
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtype
|
Hasbini, A.
|
|
|
10 |
4 |
p. 421-425
|
artikel
|
| 99 |
Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type
|
A. Hasbini
|
|
1999
|
10 |
4 |
p. 421-425
5 p.
|
artikel
|
| 100 |
Preventative Strategies for Periampullary Tumours in FAP
|
M. H. Wallace
|
|
1999
|
10 |
4 |
p. 201-203
3 p.
|
artikel
|
| 101 |
Prevention of Bile Duct Cancer in Primary Sclerosing Cholangitis
|
P.M. Harrison
|
|
1999
|
10 |
4 |
p. 208-211
4 p.
|
artikel
|
| 102 |
Primary Sclerosing Cholangitis and Cholangiocarcinoma as a Diagnostic and Therapeutic Dilemma
|
Dirk J. van Leeuwen
|
|
1999
|
10 |
4 |
p. 89-93
5 p.
|
artikel
|
| 103 |
Progress in Cancer Genetics: Lessons from Pancreatic Cancer
|
M. Goggins
|
|
1999
|
10 |
4 |
p. 4-8
5 p.
|
artikel
|
| 104 |
Quality of Life, Nutritional Status and Gastrointestinal Hormone Profile following the Whipple Procedure
|
Robin S. McLeod
|
|
1999
|
10 |
4 |
p. 281-284
4 p.
|
artikel
|
| 105 |
Rationing in cancer treatment: Is the identification of essential cytotoxic drugs feasible?
|
Sessa, C.
|
|
|
10 |
4 |
p. 373-374
|
artikel
|
| 106 |
Rationing in cancer treatment: Is the identification of essential cytotoxic drugs feasible?
|
C. Sessa
|
|
1999
|
10 |
4 |
p. 373-374
2 p.
|
artikel
|
| 107 |
Remote Partial Gastrectomy as a Risk Factor for Pancreatic Cancer: Potential for Preventive Strategies
|
B.P. van Rees
|
|
1999
|
10 |
4 |
p. 204-207
4 p.
|
artikel
|
| 108 |
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study
|
Prince, H.M.
|
|
|
10 |
4 |
p. 479-481
|
artikel
|
| 109 |
Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer: Results of a phase I study
|
H. M. Prince
|
|
1999
|
10 |
4 |
p. 479-481
3 p.
|
artikel
|
| 110 |
Retinoids in Pancreatic Cancer
|
E.O. Riecken
|
|
1999
|
10 |
4 |
p. 197-200
4 p.
|
artikel
|
| 111 |
Risk Factors for Biliary Tract Carcinogenesis
|
R.W. Chapman
|
|
1999
|
10 |
4 |
p. 308-311
4 p.
|
artikel
|
| 112 |
Risk of Pancreatic and Periampullary Cancer Following Cholecystectomy
|
Lucio Gullo
|
|
1999
|
10 |
4 |
p. 127-128
2 p.
|
artikel
|
| 113 |
Role of Endoscopic Stenting in the Duodenum
|
David L. Carr-Locke
|
|
1999
|
10 |
4 |
p. 261-264
4 p.
|
artikel
|
| 114 |
Role of Radiotherapy, in Particular Intraluminal Brachytherapy, in the Treatment of Proximal Bile Duct Carcinoma
|
D. González González
|
|
1999
|
10 |
4 |
p. 215-220
6 p.
|
artikel
|
| 115 |
Role of Tumor Markers and Mutations in Cells and Pancreatic Juice in the Diagnosis of Pancreatic Cancer
|
M. Tascilar
|
|
1999
|
10 |
4 |
p. 107-110
4 p.
|
artikel
|
| 116 |
Role of Tumour Markers, Cytogenetics
|
R. Lamerz
|
|
1999
|
10 |
4 |
p. 145-149
5 p.
|
artikel
|
| 117 |
Somatostatin Receptor Imaging and Therapy of Pancreatic Endocrine Tumors
|
C.H.J. van Eijck
|
|
1999
|
10 |
4 |
p. 177-181
5 p.
|
artikel
|
| 118 |
Standard Surgical Treatment in Pancreatic Cancer
|
M. Wagner
|
|
1999
|
10 |
4 |
p. 247-251
5 p.
|
artikel
|
| 119 |
Studies of Intraoperative Radiotherapy in Carcinoma of the Pancreas
|
William F. Sindelar
|
|
1999
|
10 |
4 |
p. 226-230
5 p.
|
artikel
|
| 120 |
Subject Index
|
|
|
1999
|
10 |
4 |
p. 313-315
3 p.
|
artikel
|
| 121 |
Surgical Palliative Treatment in Bilio-Pancreatic Malignancy
|
Dirk J. Gouma
|
|
1999
|
10 |
4 |
p. 269-272
4 p.
|
artikel
|
| 122 |
Surgical Possibilities for Bile Duct Cancer: Standard Surgical Treatment
|
Irving S. Benjamin
|
|
1999
|
10 |
4 |
p. 239-242
4 p.
|
artikel
|
| 123 |
Surgical Possibilities for Pancreatic Cancer: Extended Resection
|
B. Kremer
|
|
1999
|
10 |
4 |
p. 252-256
5 p.
|
artikel
|
| 124 |
Table of Contents
|
|
|
|
10 |
4 |
p. iii-iv
|
artikel
|
| 125 |
The Future of Surgery for Pancreatic Cancer
|
J. Slavin
|
|
1999
|
10 |
4 |
p. 285-290
6 p.
|
artikel
|
| 126 |
The Impact of Smoking on Future Pancreatic Cancer: A Computer Simulation
|
I. Mulder
|
|
1999
|
10 |
4 |
p. 74-78
5 p.
|
artikel
|
| 127 |
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign
|
Barozzi, P.
|
|
|
10 |
4 |
p. 467-469
|
artikel
|
| 128 |
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign
|
P. Barozzi
|
|
1999
|
10 |
4 |
p. 467-469
3 p.
|
artikel
|
| 129 |
The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer
|
Hamilton, A.
|
|
|
10 |
4 |
p. 377-384
|
artikel
|
| 130 |
The third-generation non-steroidal aromatase inhibitors: A review of their clinical benefits in the second-line hormonal treatment of advanced breast cancer
|
A. Hamilton
|
|
1999
|
10 |
4 |
p. 377-384
8 p.
|
artikel
|
| 131 |
Usefulness of Novel Tumour Markers
|
Jonathan M. Rhodes
|
|
1999
|
10 |
4 |
p. 118-121
4 p.
|
artikel
|
| 132 |
Vagaries of Clinical Presentation of Pancreatic and Biliary Tract Cancer
|
I. Modolell
|
|
1999
|
10 |
4 |
p. 82-84
3 p.
|
artikel
|
| 133 |
Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older
|
Vogel, C.
|
|
|
10 |
4 |
p. 397-402
|
artikel
|
| 134 |
Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older
|
C. Vogel
|
|
1999
|
10 |
4 |
p. 397-402
6 p.
|
artikel
|
| 135 |
Watchful monitoring for hepatitis B reactivation after intensive chemotheraphy
|
|
|
|
10 |
4 |
p. 483-484
|
artikel
|
| 136 |
Watchful monitoring for hepatitis B reactivation after intensive chemotherapy
|
Y. Chalandon
|
|
1999
|
10 |
4 |
p. 483-484
2 p.
|
artikel
|
| 137 |
What after managed care?
|
|
|
|
10 |
4 |
p. 365-366
|
artikel
|
Tijdschrift beschrijving